Leadership Change at Tecan Group
Tecan Group has confirmed that Chief Financial Officer Tania Micki will be departing from the company as she embarks on a new professional journey. Tania has been a pivotal member of the Management Board since February 2020, making substantial contributions to the company's financial operations.
A Smooth Transition Ahead
In a bid to ensure a seamless transition, Tania will continue in her role until May 2026. This strategic decision provides Tecan ample time to nominate her successor and apply its well-structured succession planning process.
Thanks for Valuable Contributions
The Board of Directors, along with CEO Monica Manotas, expressed their heartfelt gratitude for Tania Micki's commitment and her outstanding contributions. Her expertise has greatly optimized Tecan's financial strategy and operational excellence.
About Tecan Group
Founded in Switzerland in 1980, Tecan Group is a leader in laboratory automation. The company specializes in developing and manufacturing innovative instruments, components, and medical devices that empower healthcare professionals and laboratories worldwide. With over 3,000 employees, Tecan operates research and development facilities across Europe, North America, and Asia, ensuring that they continuously meet the advanced needs of the healthcare market.
Financial Performance and Market Position
For the fiscal year of 2024, Tecan reported impressive sales numbers, totaling CHF 934 million (equivalent to roughly USD 1,062 million and EUR 984 million). This financial success underscores Tecan's strong market position within the healthcare sector, particularly in laboratory automation.
The Road Ahead for Tecan
As Tecan looks towards the future, the company remains focused on its mission to enhance lives through healthcare innovation. The upcoming leadership transition aims to uphold the company’s reputation as a trusted partner in healthcare advancement, ensuring that Tecan maintains its trajectory of growth and excellence.
Continued Commitment to Innovation
Tecan Group is dedicated to pushing the boundaries of what's possible in laboratory automation. Their commitment to innovation ensures they remain at the forefront of the industry, continually striving to improve healthcare outcomes through advanced technology and integration.
Contact Information
For more information, Tecan’s team, led by Martin Brändle, Senior Vice President of Corporate Communications & Investor Relations, is ready to assist. They can be reached at +41 (0) 44 922 84 30 or via email at investor@tecan.com. Visit their website for further insights at www.tecan.com.
Frequently Asked Questions
Who is Tania Micki?
Tania Micki is the Chief Financial Officer of Tecan Group, serving since February 2020.
Why is Tania Micki leaving Tecan?
Tania Micki is moving on to pursue an external opportunity, with plans for a smooth transition before her departure in May 2026.
What impact has Tania had on Tecan?
Tania has significantly contributed to Tecan's financial strategy, process optimization, and operational excellence during her tenure.
When did Tecan Group achieve notable sales performance?
In 2024, Tecan Group reported sales of CHF 934 million, illustrating the company’s strong market position.
How can I contact Tecan Group for more information?
You can reach Tecan Group by calling +41 (0) 44 922 84 30 or email investor@tecan.com.